Apollo Neuroscience

Key facts

Founded

2020, Pittsburgh, Pennsylvania

Founders

David Rabin MD PhD (Chief Innovation Officer), Greg Siegle PhD (Chief Scientific Officer)

Product

Apollo Neuro - wearable touch therapy device delivering low-frequency vibration patterns to improve sleep, stress resilience, and focus

Funding

Seed $5M; Series A $15M; total ~$20M

Science

Based on Dr. Rabin research at University of Pittsburgh on touch therapy for PTSD and stress; clinically tested HRV improvement

Differentiation

Vibroacoustic touch therapy rather than tracking; active intervention device; psychiatric research foundation

Models (1)

• Apollo Neurobiometric

Current leadership (2)

• David Rabin MD PhD foundersecondary-verified
• Greg Siegle PhD foundersecondary-verified

Funding rounds (2)

• Series A2022-01-01

  $15M(reported)

• Seed2020-01-01

  $5M(reported)

Sources (2)

1. https://www.apolloneuro.com/ ↗
2. https://www.forbes.com/sites/forbesbusinesscouncil/2023/04/12/wearable-technology-for-stress-management/ ↗

Common questions

What is Apollo Neuroscience?

Wearable stress-relief device using silent touch therapy (vibrations) to improve heart rate variability, sleep, and focus. FDA-registered general wellness device.

What does Apollo Neuroscience make?

Apollo Neuroscience has 1 robot model on the DEPLOY registry: Apollo Neuro (Apollo Neuroscience builds physical robots).

Where does Apollo Neuroscience operate robots?

Apollo Neuroscience is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.